Xcout Intel
Exobiosphere
Exobiosphere is a privately held space-biotech company headquartered in Esch-sur-Alzette, Luxembourg. Founded in 2024, its mission is to extend and improve life on Earth and in space by utilizing microgravity as a new dimension for biology to accelerate drug research.
Subscribe to see Exobiosphere’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Exobiosphere at a glance
Exobiosphere is a biotech company headquartered in Luxembourg. It has raised at least $3.1M across the 2 funding rounds on record. Its most recent funding round, Grant, raised $1.1M in August 2026. Xcout tracks 3 named people at Exobiosphere, including Kyle Acierno (CEO).
Exobiosphere leadership
- Kyle AciernoCEO
- Kyle AciernoCo-Founder & Chief Executive Officer
- Mathias LinkDirector for External Affairs and Strategic Partnerships
Exobiosphere funding rounds
At least $3.1M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | $1.1M | — | |
| Seed | $2M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Exobiosphere news
Investors
Exobiosphere competitors
A few of Exobiosphere's closest competitors — see the full list of competitors and alternatives →
Space LiinTech is a space biopharma company headquartered in Daejeon, South Korea, that develops AI-enabled microgravity platforms for pharmaceutical research.
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Exa Biosciences builds infrastructure solutions designed to power the development of next-generation therapeutic biologics. The company provides foundational support and technologies tailored for organizations and researchers working in the biotherapeutic sector.
ASTRA Therapeutics is a biotechnology and drug design company focused on animal health and anti-parasitic drug discovery. Located at the Swiss Innovation Park Innovaare in Villigen, Switzerland, the company leverages atomic resolution to craft next-generation small-molecule treatments against parasitic diseases.
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Starpax Biopharma Inc. is a Canadian biotechnology research and development company incorporated in 2017 to commercialize cancer-treatment technology licensed from Polytechnique Montréal. The company has developed a platform technology utilizing magnetodrones designed to treat solid tumors while aiming to preserve organ function and avoid traditional side effects.
Get Exobiosphere's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Exobiosphere in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access